To determine whether decreased neuronal saposin levels are specific to FTLD-GRN, we also examined the levels of saposin B in more detail in controls, and individuals with AD, FTLD-GRN or corticobasal degeneration, a subtype of FTLD with tau inclusions (FTLD-tau). This evidence concerns the gene MAPT and corticobasal degeneration disorder.